| 摘要: |
| 近年来联合用药逐渐成为肿瘤治疗的研究热点,联合用药可以通过发挥药物的协同抗肿瘤作用,达到在减小化疗药物毒副作用的同时增加药物抗肿瘤效果的目的。本文综述了近年来联合用药用于肿瘤治疗的相关研究,包括:抗体-药物偶联物、多药耐药逆转剂联合抗肿瘤药、基因治疗联合抗肿瘤药以及光动力疗法联合抗肿瘤药,为联合用药的设计及应用提供参考。 |
| 关键词: 联合用药 肿瘤治疗 协同抗肿瘤 |
| DOI:10.13506/j.cnki.jpr.2017.10.010 |
| 基金项目:国家科技重大专项(No.2017ZX09101001-006);国家自然科学基金(No.81501579、81673364);江苏省自然科学基金(No.BK20150702) |
|
|
|
| Advances in antitumoral strategies with combination drug therapy |
| TANG Baoqiang,YU Yinglan,TU Jiasheng,SUN Chunmeng |
| (School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China) |
| Abstract: |
| Combination drug therapy has gradually become the focus of cancer treatment in recent years. It can minimize the side effects of chemotherapeutics as well as increase its antitumor effects via playing synergistic antitumor effect of drug.In this review, relevant recent researches of combination drug therapy for cancer treatment were reviewed,including antibody-drug conjugate,multidrug resistance reversal agents joint antineoplastic,gene therapy joint antineoplastic and photodynamic therapy joint antineoplastic,so as to provide theoretical references for the design and application of combination drug therapy. |
| Key words: Combination drug therapy Antitumor therapy Synergistic antitumor |